Company intelligence
BGBx
About BGBx
BGBx is an independent commercial solutions partner for pharmaceutical and life science companies and their brands, combining consulting, communications, science, creativity, data, technology, innovation, and digital capabilities to deliver breakthrough results. Through BGBx Consulting and BGBx Communications, the company helps clients set strategy early, stay aligned throughout the product lifecycle, and execute through marketing and communications programs that drive impact. BGBx is Built for Breakthrough.
Verified activity
Signals from BGBx
7 published signals
Research & Knowledge
BGBx published a white paper developed alongside ESC Congress 2026 on CKM syndrome, cardiovascular-kidney-metabolic syndrome, and the joint guideline that now stages it, measures it, and treats it as a single continuum.
Reported by BGBx
Research & Knowledge
BGBx published a white paper co-authored by Geoff Catalano, PhD, Samema Sarowar, PhD, and Amanda Eckel on the clinical challenges and referral pathways for CKM syndrome, cardiovascular-kidney-metabolic syndrome, and cross-specialty coordination.
Reported by BGBx
Research & Knowledge
BGBx conducted research across 800 pharma brand leaders to explore the friction in brand execution.
Reported by BGBx
People
BGBx is hiring its Kx Advisors team for open roles driven by complex challenges and strategy across pharma, biotech, and medtech.
Reported by BGBx
Research & Knowledge
BGBx published a new white paper titled The Execution Gap examining the forces making it harder to turn commercial ambition into impact.
Reported by BGBx
People
BGBx Consulting is hiring for open roles including consulting and innovation positions with Kx Advisors, Hayden Consulting Group, and BGBx’s Innovation and Intelligence team.
Reported by BGBx
Presence & Recognition
BGBx is hosting a session featuring Denise Minton Lee-Thorp and Dimpy Mehra, PharmD, RPh, exploring expert maps and disease ecosystems for identifying and engaging the right experts.
Reported by BGBx